News

Catfish skin mucus yields promising antibacterial compound

Anne Frances Johnson
March 24, 2024

Scientists report they have extracted a compound with powerful antibacterial properties from the skin of farmed African catfish. Although additional testing is necessary to prove the compound is safe and effective for use as future antibiotic, the researchers say it could one day represent a potent new tool against antimicrobial-resistant bacteria such as extended-spectrum beta-lactamase (ESBL) producing E. coli.

Hedmon Okella is a postdoctoral researcher at the University of California, Davis, and led the project.

Scientists have extracted a compound with powerful antibacterial properties from the skin of farmed African catfish. The peptide could represent a potent new tool against antimicrobial-resistant infections, according to research presented at Discover BMB in San Antonio.
Scientists extracted a compound with powerful antibacterial properties from the skin of farmed African catfish. The peptide could be a potent new tool against antimicrobial-resistant infections, according to research presented at Discover BMB in San Antonio.

“The global public health threat due to antimicrobial resistance necessitates the search for safe and effective new antibacterial compounds,” Okella said. “In this case, fish-derived antimicrobial peptides present a promising source of potential leads.”

Okella will present the new research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which is being held March 23–26 in San Antonio.

For the study, the researchers extracted several peptides (short chains of amino acids) from African catfish skin mucus and used machine learning algorithms to screen them for potential antibacterial activity. They then chemically synthesized the most promising peptide, called NACAP-II, and tested its efficacy and safety on ESBL-E. coli and mammalian blood cells, respectively.

These tests showed that NACAP-II caused the bacteria to break open, or lyse, without appearing to harm the mammalian blood cells. “Preliminary findings indicate that this promising peptide candidate potentially disrupts the bacterial cell envelope to cause lysis at a very low concentration,” Okella said.

The place where the peptide was found — in the mucus on the skin of farmed African catfish — is not as unlikely as it may seem. As anyone who has tried to hold one can attest, fish are enveloped in a slippery layer of mucus. This mucus is known to protect the fish against infections by physically carrying germs off of the skin and by producing antimicrobial compounds such as the one Okella’s team isolated.

Many existing medicines are based on compounds that were first found in nature, and scientists speculate that marine and aquatic organisms represent a particularly rich — though largely untapped — source of bioactive compounds.

As a next step, the researchers plan to study the peptide’s effects in animal models and explore strategies to produce it inexpensively.

“We are currently utilizing chemical synthesis to upscale the production of this peptide that we believe will one day be of use as drug candidate in the battle against antimicrobial resistance,” Okella said.

Hedmon Okella will present this research from 4:30 to 6:30 p.m. CDT on Sunday, March 24, in the exhibit hall of the Henry B. González Convention Center (Poster Board No. 86) (abstract). 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anne Frances Johnson

Anne Frances Johnson is founder and lead science writer at Creative Science Writing based in Chapel Hill, North Carolina. 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.

Pathogen-derived enzyme engineered for antibiotic design
Journal News

Pathogen-derived enzyme engineered for antibiotic design

Aug. 6, 2025

Engineered variants of a bacterial enzyme developed at the University at Buffalo accept larger substrates, paving the way for new acinetobactin-based antimicrobials. Read more about this recent JBC paper.

Omega-3 fats linked to healthy aging and improved heart metabolism
Journal News

Omega-3 fats linked to healthy aging and improved heart metabolism

Aug. 1, 2025

Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.